Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline

American Heart Journal Plus Cardiology Research and Practice(2022)10.1016/j.ahjo.2022.100201Source: DataRank Database

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline is a research paper published in American Heart Journal Plus Cardiology Research and Practice (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.95)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Vera Bittner ORCID,Todd M. Brown ORCID,Lisandro D. Colantonio ORCID,Nafeesa Dhalwani ORCID,Jenna Jones

Live enrichment

PubMed:37168932 PMC:PMC10168648 OpenAlex:https://openalex.org/W4293340762

NINDS NIH HHS

Grant: U01 NS041588

Amgen Inc

American College of Cardiology Foundation

University of Alabama

American Heart Association

National Institutes of Health

FWCI

2.95

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://www.sciencedirect.com/science/article/pii/S2666602222001185/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S2666602222001185/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666602222001185?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666602222001185?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ahjo.2022.100201

Fields of Study

Lipoproteins and Cardiovascular HealthMedication Adherence and ComplianceHIV-related health complications and treatments

Keywords

EzetimibeMedicineInternal medicineNational Health and Nutrition Examination SurveyPCSK9GuidelinePopulationAtherosclerotic cardiovascular diseaseStatinDiabetes mellitusCholesterolEndocrinologyLipoproteinDiseaseLDL receptorEnvironmental healthPathologyLipidAha/accAscvdPcsk9iAdd-on Lipid-lowering Therapy

Sustainable Development Goals

SDG 0: Good health and well-being